SGT-53, a transferrin receptor-targeted liposomal vector encapsulating wild-type p53 plasmid DNA is able to cross the BBB and target GBM cells, resulting in a reduction of MGMT and apoptosis in GBM xenografts in mice [60]. This evidence concerns the gene MGMT and glioblastoma.